[Federal Register Volume 72, Number 144 (Friday, July 27, 2007)]
[Notices]
[Pages 41388-41389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-14571]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting for the aforementioned 
committee:

    Times and Dates:
    8:30 a.m.-5 p.m., September 5, 2007.
    8:30 a.m.-3 p.m., September 6, 2007.
    Place: CDC, 1600 Clifton Road, NE., Tom Harkin Global 
Communications Center, Building 19, Room 232, Auditorium B, Atlanta, 
Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This Committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact on medical and laboratory practice of proposed revisions to

[[Page 41389]]

the standards; and the modification of the standards to accommodate 
technological advances.
    Matters To Be Discussed: The agenda will include updates from 
the CDC, the Centers for Medicare & Medicaid Services, and the Food 
and Drug Administration; presentations and discussions on current 
and planned CLIAC Research; an overview of the September 2007 
Institute for Critical Issues in Health Laboratory Practice: 
Managing for Better Health; an update on oversight of Genetic 
Testing; and an Introduction to Quality Management Systems for the 
Clinical Laboratory. Agenda items are subject to change as 
priorities dictate.
    New Information--Online Registration Required: In order to 
expedite security clearance process at the CDC Roybal Campus located 
on Clifton Road, all CLIAC attendees are required to register for 
the meeting online at least 30 days in advance at http://wwwn.cdc.gov/cliac/default.aspx, by clicking the ``Register for 
Meeting'' link; complete the form and click ``submit.'' Please 
complete all required fields before submitting your registration and 
submit no later than August 5, 2007.
    Providing Oral or Written Comments: It is CLIAC policy to accept 
written public comments and provide a brief period for oral public 
comments whenever possible. Oral Comments: In general, each 
individual or group requesting to make an oral presentation will be 
limited to a total time of five minutes (unless otherwise 
indicated). Speakers must also submit their comments in writing for 
inclusion in the meeting summary report. To assure adequate time is 
scheduled for public comments, individuals or groups planning to 
make an oral presentation should notify the contact person below at 
least one week prior to the meeting date. Written Comments: For 
individuals or groups unable to attend the meeting, CLIAC accepts 
written comments until the date of the meeting (unless otherwise 
stated). However, the comments should be received at least one week 
prior to the meeting date so that the comments may be made available 
to the committee for their consideration and public distribution. 
Written comments should be on hard copy with original signature 
provided to the contact person below. Written comments will be 
included in the meeting summary report.
    Contact Person for Additional Information: Nancy Anderson, 
Acting Chief, Laboratory Practice Standards Branch, Division of 
Laboratory Systems, National Center for Preparedness, Detection, and 
Control of Infectious Diseases, Coordinating Center for Infectious 
Diseases, CDC, 1600 Clifton Road, NE., Mailstop F-11, Atlanta, 
Georgia 30333; telephone (404) 718-1025; fax (404) 718-1085; or via 
e-mail at [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for CDC and the Agency for Toxic Substances and Disease 
Registry.

    Dated: July 23, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-14571 Filed 7-26-07; 8:45 am]
BILLING CODE 4163-18-P